跳至主要内容
临床试验/NCT06214871
NCT06214871招募中不适用

A Prospective Study To Evaluate Safety and Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) For Neuroenhancement

Gerrish MedEsthetics2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年11月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
2
主要终点
Sleep Quality - Jenkins Sleep Scale

研究概览

简要总结

The purpose of this pilot study is to evaluate the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Sleep Quality, Mood and Memory.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, 22 to 70 years of age
  • Freely provides written informed consent
  • In good general health, as ascertained by medical history
  • If female, not breastfeeding, no known or suspected pregnancy, a status of non- childbearing potential or use of an acceptable form of birth control
  • If subject is in menopausal transition, the subject must be stabilized on hormonal treatment.
  • Subject scored a 2 or higher on PHQ-9 sleep related question (#3), OR subject scored 2 or more on at least 2 QIDS-SR sleep related questions (#'s 1-4)
  • If subject is on any psychiatric or sleep medication, dose must be stable for two weeks prior to enrollment and remain stable throughout the trial.

排除标准

  • Subject satisfies any one or more of the contraindications for TMS Therapy per current treatment guidelines as determined by the PI.
  • History of head trauma associated with loss of consciousness or diagnosed as concussion.
  • History of fainting, syncope, hearing problems or ringing in the ears (tinnitus)
  • Has any metallic implant(s) in or near the head (e.g., pacemaker, defibrillator, neurostimulator, etc.) including any splinters, fragments, clips, etc.
  • Has an implanted stimulator device (including device leads) in or near the head.
  • (e.g. deep brain stimulator, cochlear implant, vagus nerve stimulator.)
  • Has medication infusion device.
  • Subjects with any prior TMS or MRI complications which, in the opinion of the investigator, might interfere with safety, study participation, or which might confound data interpretation,
  • Current diagnosis of a Substance Use Disorder (Abuse or Dependence, as defined by DSM-IV-TR), with the exception of nicotine dependence.
  • Current diagnosis or known history of neurologic or neuropsychiatric disease (e.g., epilepsy, convulsion, seizure)
  • Has a clinically significant abnormality on the screening examination that might affect safety, study participation, or confound interpretation of study results.
  • Participation in any clinical trial with an investigational drug or device within the past month or concurrent with study participation.

结局指标

主要结局

Sleep Quality - Jenkins Sleep Scale

时间窗: Various - Over 8 weeks

Jenkins Sleep Scale (Score can be from 0-20; higher scores equal lesser sleep quality)

Sleep Quality - PHQ-9 (Patient Health Questionnaire-9)

时间窗: Various - Over 8 Weeks

PHQ-9 (Question #3 score can be 0-3; higher score equal lesser sleep quality)

Sleep Quality - QIDS-SR (Quick Inventory of Depressive Symptomatology - Self Report)

时间窗: Various - Over 8 Weeks

QIDS-SR (Questions #1-#4 each question can be 0-3; higher score equals lesser sleep quality)

次要结局

  • Memory - RAVLT Delayed Recall(Various - Over 8 weeks)
  • Mood - PANAS (Positive and Negative Affect Schedule)(Various - Over 8 weeks)
  • Memory - RAVLT Immediate Recall (Rey Auditory Verbal Learning Test)(Various - Over 8 weeks)
  • Mood - VAMS (Visual Analog Mood Scale)(Various - Over 8 Weeks)
  • Mood - SAMMS (Sleep, Anxiety, Mood, Memory Survey)(Various - Over 8 Weeks)

研究者

发起方
Gerrish MedEsthetics
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

rTMS for Neuroenhancement | 临床试验